Department of Histology, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
Clin Exp Med. 2010 Sep;10(3):169-72. doi: 10.1007/s10238-009-0085-6. Epub 2009 Dec 24.
Vascular endothelial growth factor-A (VEGF-A) and hepatocyte growth factor (HGF) are well known angiogenesis inductors and promoters in normal and pathologic conditions. Recent data showed that VEGF-A and HGF could also influence lymphangiogenesis but this matter has not been completely elucidated. Administration of VEGF-A and HGF in combination has been used to improve the angiogenic response in different experimental models, but their effects on lymphangiogenesis have not been investigated. The aim of this study was to characterize blood and lymphatic vascular response to VEGF-A/HGF administration. To this purpose, we built a pBlast VEGF-A/HGF combination suitable for in vivo research. By using as an experimental in vivo model the chick embryo chorioallantoic membrane (CAM) assay, we applied pBlast VEGF-A/HGF combination for 7 days. Results showed that VEGF-A/HGF combination was able to induce a strong angiogenic response and the expression of Prox-1 in the lymphatic endothelial cells of the CAM. The possible mechanisms involved have been speculated.
血管内皮生长因子-A(VEGF-A)和肝细胞生长因子(HGF)是正常和病理条件下已知的血管生成诱导剂和促进剂。最近的数据表明,VEGF-A 和 HGF 也可以影响淋巴管生成,但这一问题尚未完全阐明。在不同的实验模型中,已经使用 VEGF-A 和 HGF 的联合给药来改善血管生成反应,但尚未研究它们对淋巴管生成的影响。本研究的目的是描述 VEGF-A/HGF 给药对血液和淋巴管的反应。为此,我们构建了一种适用于体内研究的 pBlast VEGF-A/HGF 组合。我们使用鸡胚尿囊膜(CAM)实验作为体内实验模型,将 pBlast VEGF-A/HGF 组合应用于 CAM 7 天。结果表明,VEGF-A/HGF 组合能够诱导强烈的血管生成反应和 Prox-1 在 CAM 淋巴管内皮细胞中的表达。推测了可能涉及的机制。